Vagus Nerve Stimulation Helps Seizures in TSC Patients

Credibility

Interest

Share:2 min read

Key Takeaway

Vagus nerve stimulation (VNS) helped many people with tuberous sclerosis complex (TSC) who have hard-to-control seizures, lowering seizures and improving thinking and life quality.

What They Found

This study followed 70 people with TSC and drug-resistant epilepsy who could not have brain surgery and compared those who got VNS (20 people) to those on medicines only (50 people). After 1 to 3 years, about 65%–75% of the VNS group had a strong drop in seizures, while only about 31%–36% of the medicine-only group did. People with VNS also had a bigger drop in how often seizures happened and fewer seizures came back over time. By two years, the VNS group used fewer anti-seizure medicines and showed better scores on simple thinking tests (IQ) and quality-of-life questions. The treatment was safe overall, with only mild surgery problems and no permanent bad effects reported.

Who Should Care and Why

People with TSC whose seizures do not get better with medicine and who cannot have removal surgery may benefit from VNS because it can lower seizures when other options are limited. Caregivers should know VNS might mean fewer medicines to manage, which can reduce side effects like tiredness or mood changes. Doctors and epilepsy nurses can consider VNS as a practical tool to help patients who otherwise have few choices, similar to switching to a different tool when the first one breaks. Families may notice daily improvements, such as better alertness, learning, or mood, since the study found gains in thinking and quality of life. This option is most relevant for patients with many seizure-causing areas in the brain that cannot be safely removed.

Important Considerations

This study was not a randomized trial, which means patients chose or were chosen for VNS vs medicine and that can affect results. The number of people getting VNS was smaller (20 people), so results are encouraging but need confirmation in bigger randomized studies. While VNS looked safe here, individual risks and benefits should be discussed with your specialist because every person and surgery is different.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Treatment Updates Clinical Trials Specific Symptoms

Article Topics:

epilepsyprospective cohort studytuberous sclerosis complexvagus nerve stimulation

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Epilepsia often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News